Gregory Norden

Gregory Norden currently works at Zoetis, Inc., as Independent Director from 2014, RP Management LLC, as Director, G9 Capital Group LLC, as Managing Director from 2010, Praxis Precision Medicines, Inc., as Independent Director from 2019, Anthos Therapeutics, Inc., as Director from 2019, and Royalty Pharma Plc, as Independent Director from 2020.
Mr. Norden also formerly worked at AMAG Pharma USA, Inc., as Director from 2013 to 2014, Human Genome Sciences, Inc., as Independent Director from 2011 to 2012, Univision Communications, Inc., as Director, Welch Allyn, Inc., as Director, Greatwide Logistics Services LLC, as Director, Univision Holdings, Inc., as Director, Entasis Therapeutics, Inc., as Independent Director, Entasis Therapeutics Holdings, Inc., as Independent Director, NS Wind Down Co., Inc., as Independent Director from 2012 to 2024, Wyeth Pharmaceuticals LLC, as Chief Financial Officer & Executive Vice President, Arthur Andersen LLP, as Audit Manager, Ayerst Laboratories, Inc., as Vice President-Finance from 1996 to 1999, Arthur Andersen & Co., as Audit Manager, and Wyeth LLC, as Chief Financial Officer & Senior Vice President from 1989 to 2009.
Mr. Norden received his undergraduate degree from State University of New York College at Plattsburgh and graduate degree from Long Island University.